Evidence map›Paper›PMID 23879373›Full record

ArticleJournal of sleep research2013

Selective serotonin 2A receptor antagonism attenuates the effects of amphetamine on arousal and dopamine overflow in non-human primates.

Kevin S Murnane, Monica L Andersen, Kenner C Rice, Leonard L Howell

Open access · greenAbstract read
In one paragraph

Article in Journal of sleep research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Classics in Chemical Neuroscience: Aripiprazole.ACS chemical neuroscience · 2017
    Review
  13. Article
  14. Review
  15. The serotonin 5-HTJournal of psychopharmacology (Oxford, England) · 2017
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Kevin S Murnane
Monica L Andersen
Kenner C Rice
Leonard L Howell
Emory National Primate Research CenterEmory University · USNational Institutes of Health · US

Funding

YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
COCAINE USE AND MONOAMINE FUNCTION IN NONHUMAN PRIMATESR01DA012514 · NIDA · EMORY UNIVERSITY · PI HOWELL, LEONARD L · 2000 to 2014
$5.5M
PET Imaging and Cocaine Neuropharmacology in MonkeysR37DA010344 · NIDA · EMORY UNIVERSITY · PI HOWELL, LEONARD L · 2007 to 2015
$4.9M
Medicinal Chemistry of Drugs Acting on Biogenic Amine ReceptorsZIADA000532 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI RICE, KENNER · 2009 to 2020
$4.5M
PET IMAGING AND COCAINE NEUROPHARMACOLOGY IN MONKEYSR01DA010344 · NIDA · EMORY UNIVERSITY · PI HOWELL, LEONARD L · 1997 to 2006
$2.7M
Neuropharmacology of Abused Stimulants in Nonhuman PrimatesK05DA031246 · NIDA · EMORY UNIVERSITY · PI HOWELL, LEONARD L · 2012 to 2016
$619k
Intramural NIH HHSNCRR NIH HHS P51 RR000165NCRR NIH HHS RR000165NIDA NIH HHS DA010344NIDA NIH HHS DA012514NIDA NIH HHS K05 DA031246NIDA NIH HHS R01 DA010344NIDA NIH HHS R01 DA012514NIDA NIH HHS R37 DA010344
6 · The paper itself

Abstract

The objective of the present study was to further elucidate the mechanisms involved in the wake-promoting effects of psychomotor stimulants. Many previous studies have tightly linked the effects of stimulants to dopamine neurotransmission, and some studies indicate that serotonin 2A receptors modulate these effects. However, the role of dopamine in arousal is controversial, most notably because dopamine neurons do not change firing rates across arousal states. In the present study, we examined the wake-promoting effects of the dopamine-releaser amphetamine using non-invasive telemetric monitoring. These effects were evaluated in rhesus monkeys as a laboratory animal model with high translational relevance for human disorders of sleep and arousal. To evaluate the role of dopamine in the wake-promoting effects of amphetamine, we used in vivo microdialysis targeting the caudate nucleus, as this approach provides clearly interpretable measures of presynaptic dopamine release. This is beneficial in the present context because some of the inconsistencies between previous studies examining the role of dopamine in arousal may be related to differences between postsynaptic dopamine receptors. We found that amphetamine significantly and dose-dependently increased arousal at doses that engendered higher extracellular dopamine levels. Moreover, antagonism of serotonin 2A receptors attenuated the effects of amphetamine on both wakefulness and dopamine overflow. These findings further elucidate the role of dopamine and serotonin 2A receptors in arousal, and they suggest that increased dopamine neurotransmission may be necessary for the wake-promoting effects of amphetamine, and possibly other stimulants.

Indexed as

AmphetamineAnimalsArousalCaudate NucleusCentral Nervous System StimulantsCircadian RhythmDopamineDopamine Uptake InhibitorsFemaleFluorobenzenesMacaca mulattaMicrodialysisPiperidinesReceptors, DopamineReceptor, Serotonin, 5-HT2ASerotonin 5-HT2 Receptor AntagonistsAmphetamineCentral Nervous System StimulantsDopamineDopamine Uptake InhibitorsFluorobenzenesPiperidinesReceptors, DopamineReceptor, Serotonin, 5-HT2ASerotonin 5-HT2 Receptor Antagonistsvolinanserin

Identifiers

PMID23879373
PMCPMC3808463
OpenAlexW2092052097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.